Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Heidelbaugh J, Kim AH, Chang R, Walker PC. Overutilization of proton-pump inhibitors: what the clinician needs to know. Therapy Adv Gastroenterol. 2012;5:219–32.
2. Friedenberg FK, Hanlon A, Vanar V, Nehemia D, Mekapati J, Nelson DB, et al. Trends in gastroesophageal reflux disease as measured by the National Ambulatory Medical Care Survey. Dig Dis Sci. 2010;55:1911–7.
3. IMS Health Reports U.S. Prescription Sales Grew 3.8 Percent in 2007, to $286.5 Billion. 2008. http://www.businesswire.com/news/home/20080312005158/en/IMS-Health-Reports-U.S.-Prescription-Sales-Grew .
4. Maggio M, Corsonello A, Ceda GP, Cattabiani C, Lauretani F, Butto V, et al. Proton Pump Inhibitors and Risk of 1-Year Mortality and hospitalization in older patients discharged from acute care hospitals. JAMA Intern Med. 2013;173:518–23.
5. Charlot M, Grove EL, Hansen PR, Olesen JB, Ahlehoff O, Selmer C, et al. Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study. BMJ. 2011;342:d2690. doi: 10.1136/bmj.d2690 .
Cited by
107 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献